XyloCor Therapeutics Completes Oversubscribed $41.9 Million Series A Financing To Advance Novel Gene Therapy Pipeline For Coronary Artery Disease

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/3tL6C7Q
via IFTTT